Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00700687 · ClinicalTrials.gov registry record · Phase 1
Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib
A Phase 1 study, sponsored by POZEN.
- Completed
- Registry status
- Phase 1
- Development phase
- 90
- Enrollment target
NCT00700687 is a Phase 1 study that has completed, run by POZEN. The registered enrollment target is 90 participants.
The verdict
NCT00700687, a Phase 1 study, has completed, sponsored by POZEN.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 90 participants
- Enrollment target
Study Summary
We will evaluate the effect on the gastroduodenal mucosa from oral dosing of three different treatments
Interventions
- DRUG PA32540
- DRUG PA32540 and celecoxib
- DRUG aspirin and [NSAID]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2008-06 |
| Est. Completion | 2008-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00700687
The ClinicalTrials.gov registry entry for NCT00700687 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is POZEN, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PA32540 is the first listed.
NCT00700687 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00700687 about?
NCT00700687 is a clinical study titled "Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib". We will evaluate the effect on the gastroduodenal mucosa from oral dosing of three different treatments
What is the current status of trial NCT00700687?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 90 participants. The study started on 2008-06. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00700687?
The interventions under investigation include: PA32540 (DRUG), PA32540 and celecoxib (DRUG), aspirin and [NSAID] (DRUG).
Who is sponsoring clinical trial NCT00700687?
This trial is sponsored by POZEN, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.